オクトレオチドの世界市場レポート 2025

オクトレオチド市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）5.3％で31億8,000万米ドルに成長します。予測期間における成長の背景には、高齢者人口の増加、認知度の向上と早期診断、重症下痢の発生率の上昇、ヘルスケア支出の増加、薬剤パイプラインの拡大などがあります。主な動向としては、新薬の上市、新製品の導入、規制当局の承認、技術革新、新興市場への進出などが挙げられます。

がんの罹患率の上昇が、今後数年間のオクトレオチド市場の成長を牽引すると予想されます。がんは、体内の異常細胞の制御不能な増殖と拡散を特徴とする疾患群です。がん患者の増加は、主に人口の高齢化、環境の影響、ライフスタイル要因、検出方法の進歩に起因しています。オクトレオチドは、腫瘍の成長を抑制し、ホルモンに関連するがんを管理し、関連する症状を緩和することにより、増大するがん負担に対処する上で重要な役割を果たしています。例えば、2024年5月、米国の政府機関である国立がん研究所（NCI）は、世界中で約2,000万人が新たにがんに罹患し、970万人が死亡したと報告しました。2040年の予測では、患者数は2,990万人、死亡者数は1,530万人に増加します。その結果、がん罹患率の上昇がオクトレオチド市場の拡大に拍車をかけています。

オクトレオチド市場の主要企業は、患者のアドヒアランスと利便性を高めるため、注射用懸濁液などの革新的製品の開発を優先しています。これらの注射用懸濁液は、注射によって投与される即効性のある薬剤であり、消化器系をバイパスしてより早く作用が発現する一方で、血流への迅速な吸収を保証します。例えば、2024年10月、イスラエルの製薬会社テバ・ファーマシューティカルズは、サンドスタチンLARデポ（オクトレオチド酢酸塩注射懸濁液）のジェネリック医薬品を発売しました。この注射用製剤は吸収が速く、経口薬に代わる効果的な治療薬として設計されています。天然ホルモンであるソマトスタチンの合成アナログであるオクトレオチドは、先端巨大症、カルチノイド症候群、VIP分泌腫瘍などの治療に広く使用されています。注射剤であるため作用発現が早く、患者の治療アドヒアランスを向上させる。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界オクトレオチド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のオクトレオチド市場：成長率分析
• 世界のオクトレオチド市場の実績：規模と成長, 2019-2024
• 世界のオクトレオチド市場の予測：規模と成長, 2024-2029, 2034F
• 世界オクトレオチド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオクトレオチド市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オクトレオチドアセテート
• オクトレオチド
• オクトレオチド塩化物
• オクトレオチド塩酸塩
• インジウムIn-111オクトレオチド
• 世界のオクトレオチド市場：形態別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射
• 粉
• マイクロスフェア
• 世界のオクトレオチド市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 下痢
• 先端巨大症
• その他の適応症
• 世界のオクトレオチド市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界のオクトレオチド市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 臨床調査
• 世界のオクトレオチド市場オクトレオチドアセテートのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• デポ注射剤
• 世界のオクトレオチド市場オクトレオチドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 経口製剤
• 世界のオクトレオチド市場、オクトレオチド塩化物のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 凍結乾燥粉末
• 世界のオクトレオチド市場、オクトレオチド塩酸塩のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• 凍結乾燥粉末
• 世界のオクトレオチド市場インジウムIn-111オクトレオチドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断用放射性医薬品製剤
• 治療用放射性医薬品製剤

第7章 地域別・国別分析

• 世界のオクトレオチド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のオクトレオチド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オクトレオチド市場：競合情勢
• オクトレオチド市場：企業プロファイル
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ipsen S.A.
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Bachem Holding AG
• Chemi S.p.A.
• LGM Pharma LLC
• Hainan Shuangcheng Pharmaceuticals Co. Ltd.
• USV Private Limited
• ChemWerth Inc.
• Shanghai Soho-Yiming Pharmaceuticals Co. Ltd.
• Neiss Labs Private Limited
• Samarth Life Sciences Private Limited
• TAPI Technology & API Services
• BCN Peptides S.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オクトレオチド市場2029：新たな機会を提供する国
• オクトレオチド市場2029：新たな機会を提供するセグメント
• オクトレオチド市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Octreotide is a synthetic somatostatin analog used to treat various medical conditions by inhibiting hormone secretion. Available in both short-acting and long-acting formulations, it helps manage hormone-related disorders but may lead to side effects such as gastrointestinal issues and gallstones.

The primary types of octreotide include octreotide acetate, octreotide, octreotide chloride, octreotide hydrochloride, and indium in-111 octreotide. Octreotide acetate is a synthetic somatostatin analog used to treat hormone-secreting tumors, acromegaly, and severe diarrhea associated with certain cancers. These variants are available in multiple forms, including injections, powders, and microspheres, and are prescribed for conditions such as diarrhea, acromegaly, and other related disorders. Octreotide is distributed through hospital pharmacies, online pharmacies, and retail pharmacies, with end users primarily in the pharmaceutical and clinical research sectors.

The octreotide market research report is one of a series of new reports from The Business Research Company that provides octreotide market statistics, including the octreotide industry global market size, regional shares, competitors with the octreotide market share, detailed octreotide market segments, market trends, and opportunities, and any further data you may need to thrive in the octreotide industry. This octreotide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The octreotide market size has grown strongly in recent years. It will grow from $2.45 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the rising prevalence of acromegaly and hormonal disorders, greater awareness of early diagnosis, the expansion of healthcare infrastructure, and an increase in cancer diagnoses.

The octreotide market size is expected to see strong growth in the next few years. It will grow to $3.18 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the increasing geriatric population, rising awareness and early diagnosis, a higher occurrence of severe diarrhea, growing healthcare spending, and an expanding pipeline of drugs. Key trends include advanced drug launches, new product introductions, regulatory approvals, technological innovations, and expansion into emerging markets.

The rising incidence of cancer is expected to drive the growth of the octreotide market in the coming years. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells within the body. The increase in cancer cases is primarily attributed to aging populations, environmental influences, lifestyle factors, and advancements in detection methods. Octreotide plays a crucial role in addressing the growing cancer burden by inhibiting tumor growth, managing hormone-related cancers, and alleviating associated symptoms. For example, in May 2024, the National Cancer Institute (NCI), a US-based government agency, reported nearly 20 million new cancer cases and 9.7 million deaths worldwide. Projections for 2040 indicate an increase to 29.9 million cases and 15.3 million deaths. As a result, the rising cancer rates are fueling the expansion of the octreotide market.

Leading companies in the octreotide market are prioritizing the development of innovative products, such as injectable suspensions, to enhance patient adherence and convenience. These injectable suspensions are fast-acting medications administered via injection, ensuring quicker absorption into the bloodstream while bypassing the digestive system for a faster onset of action. For instance, in October 2024, Teva Pharmaceuticals, an Israel-based pharmaceutical company, introduced a generic version of Sandostatin LAR Depot (octreotide acetate for injectable suspension). This injectable formulation is designed for rapid absorption, offering an effective alternative to oral medications. Octreotide, a synthetic analog of the natural hormone somatostatin, is widely used to treat conditions such as acromegaly, carcinoid syndrome, and VIP-secreting tumors. The injectable delivery method ensures a faster onset of action, improving treatment adherence for patients.

In April 2023, Chiesi Farmaceutici S.p.A., an Italy-based pharmaceutical company, acquired Amryt Pharma Plc for an undisclosed sum. This strategic acquisition expands Chiesi's presence in the rare disease sector, strengthening its ability to provide innovative treatments. The deal further supports Chiesi's commitment to improving patient access to transformative therapies for rare and complex conditions. Amryt Pharma Plc, an Ireland-based biopharmaceutical company, specializes in the development and commercialization of octreotide-based treatments for rare and orphan diseases.

Major players in the octreotide market are Novartis International AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Ipsen S.A., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Bachem Holding AG, Chemi S.p.A., LGM Pharma LLC, Hainan Shuangcheng Pharmaceuticals Co. Ltd., USV Private Limited, ChemWerth Inc., Shanghai Soho-Yiming Pharmaceuticals Co. Ltd., Neiss Labs Private Limited, Samarth Life Sciences Private Limited, TAPI Technology & API Services, and BCN Peptides S.A.

North America was the largest region in the octreotide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in octreotide report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the octreotide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The octreotide market consists of sales of short-acting octreotide formulations, long-acting octreotide formulations, and other extended-release formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Octreotide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on octreotide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for octreotide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The octreotide market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Octreotide Acetate; Octreotide; Octreotide Chloride; Octreotide Hydrochloride; Indium In-111 Octreotide
• 2) By Form: Injection; Powder; Microspheres
• 3) By Indications: Diarrhea; Acromegaly; Other Indications
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End-user: Pharmaceutical; Clinical Research
• Subsegments:
• 1) By Octreotide Acetate: Injectable Formulation; Depot Injectable Formulation
• 2) By Octreotide: Injectable Formulation; Oral Formulation
• 3) By Octreotide Chloride: Injectable Formulation; Lyophilized Powder
• 4) By Octreotide Hydrochloride: Injectable Formulation; Lyophilized Powder
• 5) By Indium In-111 Octreotide: Diagnostic Radiopharmaceutical Formulation; Therapeutic Radiopharmaceutical Formulation
• Companies Mentioned: Novartis International AG; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Fresenius Kabi AG; Sun Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Octreotide Market Characteristics

3. Octreotide Market Trends And Strategies

4. Octreotide Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Octreotide Growth Analysis And Strategic Analysis Framework

• 5.1. Global Octreotide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Octreotide Market Growth Rate Analysis
• 5.4. Global Octreotide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Octreotide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Octreotide Total Addressable Market (TAM)

6. Octreotide Market Segmentation

• 6.1. Global Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Octreotide Acetate
• Octreotide
• Octreotide Chloride
• Octreotide Hydrochloride
• Indium In-111 Octreotide
• 6.2. Global Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injection
• Powder
• Microspheres
• 6.3. Global Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diarrhoea
• Acromegaly
• Other Indications
• 6.4. Global Octreotide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Octreotide Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical
• Clinical Research
• 6.6. Global Octreotide Market, Sub-Segmentation Of Octreotide Acetate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulation
• Depot Injectable Formulation
• 6.7. Global Octreotide Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulation
• Oral Formulation
• 6.8. Global Octreotide Market, Sub-Segmentation Of Octreotide Chloride, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulation
• Lyophilized Powder
• 6.9. Global Octreotide Market, Sub-Segmentation Of Octreotide Hydrochloride, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulation
• Lyophilized Powder
• 6.10. Global Octreotide Market, Sub-Segmentation Of Indium In-111 Octreotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Radiopharmaceutical Formulation
• Therapeutic Radiopharmaceutical Formulation

7. Octreotide Market Regional And Country Analysis

• 7.1. Global Octreotide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Octreotide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Octreotide Market

• 8.1. Asia-Pacific Octreotide Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Octreotide Market

• 9.1. China Octreotide Market Overview
• 9.2. China Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Octreotide Market

• 10.1. India Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Octreotide Market

• 11.1. Japan Octreotide Market Overview
• 11.2. Japan Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Octreotide Market

• 12.1. Australia Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Octreotide Market

• 13.1. Indonesia Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Octreotide Market

• 14.1. South Korea Octreotide Market Overview
• 14.2. South Korea Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Octreotide Market

• 15.1. Western Europe Octreotide Market Overview
• 15.2. Western Europe Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Octreotide Market

• 16.1. UK Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Octreotide Market

• 17.1. Germany Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Octreotide Market

• 18.1. France Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Octreotide Market

• 19.1. Italy Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Octreotide Market

• 20.1. Spain Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Octreotide Market

• 21.1. Eastern Europe Octreotide Market Overview
• 21.2. Eastern Europe Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Octreotide Market

• 22.1. Russia Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Octreotide Market

• 23.1. North America Octreotide Market Overview
• 23.2. North America Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Octreotide Market

• 24.1. USA Octreotide Market Overview
• 24.2. USA Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Octreotide Market

• 25.1. Canada Octreotide Market Overview
• 25.2. Canada Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Octreotide Market

• 26.1. South America Octreotide Market Overview
• 26.2. South America Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Octreotide Market

• 27.1. Brazil Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Octreotide Market

• 28.1. Middle East Octreotide Market Overview
• 28.2. Middle East Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Octreotide Market

• 29.1. Africa Octreotide Market Overview
• 29.2. Africa Octreotide Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Octreotide Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Octreotide Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Octreotide Market Competitive Landscape And Company Profiles

• 30.1. Octreotide Market Competitive Landscape
• 30.2. Octreotide Market Company Profiles
  • 30.2.1. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Octreotide Market Other Major And Innovative Companies

• 31.1. Ipsen S.A.
• 31.2. Aurobindo Pharma Limited
• 31.3. Dr. Reddy's Laboratories Ltd.
• 31.4. Hikma Pharmaceuticals PLC
• 31.5. Bachem Holding AG
• 31.6. Chemi S.p.A.
• 31.7. LGM Pharma LLC
• 31.8. Hainan Shuangcheng Pharmaceuticals Co. Ltd.
• 31.9. USV Private Limited
• 31.10. ChemWerth Inc.
• 31.11. Shanghai Soho-Yiming Pharmaceuticals Co. Ltd.
• 31.12. Neiss Labs Private Limited
• 31.13. Samarth Life Sciences Private Limited
• 31.14. TAPI Technology & API Services
• 31.15. BCN Peptides S.A.

32. Global Octreotide Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Octreotide Market

34. Recent Developments In The Octreotide Market

35. Octreotide Market High Potential Countries, Segments and Strategies

• 35.1 Octreotide Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Octreotide Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Octreotide Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer